This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Merck Patent Gmbh. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Gerald Reese: Innovator in Allergen Research
Introduction
Gerald Reese is a notable inventor based in Langen, Germany. He has made significant contributions to the field of allergen research, particularly focusing on reducing allergenicity in true grasses. With a total of 2 patents, his work has implications for allergy treatment and management.
Latest Patents
Gerald Reese's latest patents include innovative approaches to allergen modification. The first patent, titled "Variants of group 5 allergens of the true grasses having reduced allergenicity due to mutagenesis of proline residues," describes the preparation and use of recombinant variants of group 5 allergens from the Poaceae family. These variants exhibit reduced IgE reactivity compared to known wild-type allergens while retaining significant reactivity with T-lymphocytes. The second patent, "Variants of group 6 allergens of the true grasses having reduced allergenicity due to mutagenesis of proline residues," follows a similar theme, focusing on group 6 allergens and their potential for reduced allergenic responses.
Career Highlights
Gerald Reese is currently associated with Merck Patent GmbH, where he continues to advance his research in allergen modification. His work is pivotal in developing safer alternatives for individuals with grass allergies.
Collaborations
Throughout his career, Gerald has collaborated with esteemed colleagues, including Martin Wald and Andreas Nandy. These partnerships have enhanced the scope and impact of his research.
Conclusion
Gerald Reese's innovative work in allergen research is paving the way for advancements in allergy treatment. His patents reflect a commitment to improving the quality of life for those affected by grass allergies.